//knekt.tv/knekttv-en/video/knekttvarchive/64201/64204-season-1/134035-sernova-tsxv-sva-cgm-will-be-provided-to-patients-for-a-clinical-trial-of-i

KNEKT®tv

HomeInvestment Pitch S1:E454 Sernova (TSXV: SVA) "CGM" will be provided to patients for a clinical trial of i

S1:E454 Sernova (TSXV: SVA) "CGM" will be provided to patients for a clinical trial of i

Investment Pitch | Season 1

Sernova Corp., a clinical stage company developing regenerative medicine technologies for the treatment of chronic diseases including diabetes and hemophilia, announced that continuous glucose monitoring systems "CGM" (Medtronic Minimed, Northridge, CA) will be provided to patients in Sernova's US regenerative medicine clinical trial of its Cell Pouch™.